Menu

Crinetics Pharmaceuticals Inc CRNX

Full chart Compare
Set alert

Price alert · CRNX

All alert types
84.95 USD 0.00 (+0.00%)

At closeAug 31, 2026, 4:00 PM EDT

37.84 -47.11 -55.46%

After hours · Aug 31, 4:00 PM ET

84.92 Day range 85.01
32.30 52-week range 85.01
YTD
+82.49%
1 year
+183.26%

Revenue & Expenses

Other Income → Expenses: $51.63MExpenses → Selling, General & Admin: $191.33MExpenses → Research & Development: $332.06MExpenses → Income Tax: $180.00KGross Profit → Expenses: $6.62MRevenue → Gross Profit: $6.62MRevenue → Cost of Revenue: $1.08MNet Loss → Expenses: $465.32MOther Income$51.63MGross Profit$6.62MNet Loss$465.32MCost of Revenue$1.08MExpenses$523.57MSelling, General & Admin$191.33MResearch & Development$332.06MIncome Tax$180.00KRevenue$7.70M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CRNX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
7.70M1.04M4.01M4.74M1.08M
6.62M1.04M4.01M4.74M1.08M
-516.77M-338.85M-222.61M-167.88M-107.70M
-465.32M-298.41M-214.53M-163.92M-107.64M
-4.95-3.69-3.69-3.15-2.80
CRNX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
101.54M265.05M54.90M33.97M201.19M
1.13B1.43B635.35M352.18M351.01M
134.17M109.79M96.25M35.85M19.07M
48.54M51.72M51.73M3.08M3.07M
992.08M1.32B539.11M316.33M331.94M
CRNX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-377.92M-230.19M-168.60M-115.20M-88.59M
173.91M-574.82M-200.41M-173.98M-56.48M
40.61M1.01B391.24M121.96M252.68M
-5.76M-3.84M-4.69M-1.66M-436.00K
-163.40M209.65M22.22M-167.22M107.61M